Prevalence of Sarcopenia and Its Association With Diabetes: A Meta-Analysis of Community-Dwelling Asian Population.
Reads0
Chats0
TLDR
A meta-analysis of studies on the community-dwelling population to investigate the prevalence of sarcopenia and its association with diabetes was performed in this paper, where the authors reported that the prevalence was significantly higher in diabetics than in non-diabetics.Abstract:
Purpose: Sarcopenia is a major disease affecting mortality and quality of life in the elderly population. We performed a meta-analysis of studies on the community-dwelling population to investigate the prevalence of sarcopenia and its association with diabetes. Methods: Databases were searched for studies published up to February 3, 2021, reporting the prevalence of sarcopenia in patients with and without diabetes. Data extraction and quality assessment were performed according to the Newcastle-Ottawa scale. Results: Six articles were included in the systematic review. All the patients were Asian, aged ≥60 years (women 53.4%), and the diabetic and non-diabetic population was 1,537 and 5,485, respectively. In all six studies, the Asian Working Group for Sarcopenia criteria were used to diagnose sarcopenia. The prevalence of sarcopenia was 15.9% in diabetics and 10.8% in non-diabetics. Diabetics showed a significantly higher risk of sarcopenia than non-diabetics (pooled OR = 1.518, 95% CI = 1.110 to 2.076, Z-value = 2.611, p = 0.009). Conclusion: Among the Asian community-dwelling geriatric population, the prevalence of sarcopenia was significantly higher in diabetics than in non-diabetics. These results suggest that strategies for the management of sarcopenia are required in Asian elderly patients, especially with diabetes.read more
Citations
More filters
Journal ArticleDOI
A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction
TL;DR: Future research should focus on sarcopenia biological pathway and improved diagnostic approaches such as biomarkers for early detection, development of consistently pre-eminent treatment methods for severe sarc Openia patients, and establishing sensitive measures for predicting sarcopenian treatment response.
Journal ArticleDOI
Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research
Camila E. Orsso,Montserrat Montes-Ibarra,Merran Findlay,Barbara S. van der Meij,Marian A. E. de van der Schueren,Francesco Landi,Alessandro Laio,Carla M. Prado +7 more
TL;DR: Although many trials have similar type of interventions, methodological heterogeneity may challenge study comparisons, and future meta‐analyses aiming to provide evidence‐based recommendations may benefit from guidelines for the assessment of therapeutic effects of nutrition interventions.
Journal ArticleDOI
The effect of different exercise programs on sarcopenia criteria in older people: A systematic review of systematic reviews with meta-analysis.
TL;DR: In this article , the authors compared the results of different modalities of physical exercises on the sarcopenia diagnostic criteria in older people, and compared results of resistance training interventions (RTA) with other than resistance (Non-resistance Training interventions: NRTA).
Journal ArticleDOI
Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men
Li Meng,Ruiyue Yang,Daguang Wang,Wenbin Wu,Jing-dong Shi,Ji Shen,Ya-min Dang,Guoqing Fan,Hong-yan Shi,Jun Dong,Huan Xi,Pulin Yu +11 more
TL;DR: Wang et al. as discussed by the authors measured the concentrations of amino acids, carnitine, acylcarnitines, and lysophosphatidylcholines (LPCs) in serum samples from a cross-sectional study of 246 Chinese older men, using targeted metabolomics.
Journal ArticleDOI
Eating Speed Is Associated with the Presence of Sarcopenia in Older Patients with Type 2 Diabetes: A Cross-Sectional Study of the KAMOGAWA-DM Cohort
Yoshitaka Hashimoto,Fuyuko Takahashi,Ayumi Kaji,Ryosuke Sakai,Takuro Okamura,Noriyuki Kitagawa,Hiroshi Okada,Naoko Nakanishi,Saori Majima,Takafumi Senmaru,Emi Ushigome,Mai Asano,Masahide Hamaguchi,Masahiro Yamazaki,Michiaki Fukui +14 more
TL;DR: Having a slow eating speed is associated with a heightened risk of sarcopenia in older patients with T2D, and patients with a sloweating speed had greater prevalence of low skeletal muscle mass, low muscle strength, and sarc Openia than those with a fast or normal eating speed.
References
More filters
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
TL;DR: The Newcastle-Ottawa Scale (NOS) as discussed by the authors was developed to assess the quality of nonrandomised studies with its design, content and ease of use directed to the task of incorporating the quality assessments in the interpretation of meta-analytic results.
Journal ArticleDOI
Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People
Alfonso J. Cruz-Jentoft,Jean-Pierre Baeyens,Jürgen M. Bauer,Yves Boirie,Tommy Cederholm,Francesco Landi,Finbarr C. Martin,Jean-Pierre Michel,Yves Rolland,Stéphane M. Schneider,Eva Topinkova,Maurits Vandewoude,Mauro Zamboni +12 more
TL;DR: The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia as discussed by the authors.
Journal ArticleDOI
Sarcopenia: Revised European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft,Gulistan Bahat,Jürgen M. Bauer,Yves Boirie,Olivier Bruyère,Tommy Cederholm,Cyrus Cooper,Francesco Landi,Yves Rolland,Avan Aihie Sayer,Stéphane M. Schneider,Cornel C. Sieber,Eva Topinkova,Maurits Vandewoude,Marjolein Visser,Mauro Zamboni +15 more
TL;DR: An emphasis is placed on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarc Openia diagnosis, and provides clear cut-off points for measurements of variables that identify and characterise sarc openia.
Journal ArticleDOI
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem,Mark Helfand,Mark Helfand,Holger J. Schünemann,Andrew D Oxman,Regina Kunz,Jan Brozek,Gunn Elisabeth Vist,Yngve Falck-Ytter,Joerg J Meerpohl,Susan L Norris,Gordon H. Guyatt +11 more
TL;DR: The approach of GRADE to rating quality of evidence specifies four categories-high, moderate, low, and very low-that are applied to a body of evidence, not to individual studies.
Journal ArticleDOI
Epidemiology of Sarcopenia among the Elderly in New Mexico
Richard N. Baumgartner,Kathleen M. Koehler,Dympna Gallagher,Linda J. Romero,Steven B. Heymsfield,Robert Ross,Philip J. Garry,Robert D. Lindeman +7 more
TL;DR: Some of the first estimates of the extent of the public health problem posed by sarcopenia are provided, independent of ethnicity, age, morbidity, obesity, income, and health behaviors.